Thursday, May 10, 2018

EOD Review On 09-May-2018 : Calls for Next Trading Day

www.AamAadmiSoftware.com (EOD Review on 09 May 2018)

My System Calls:

1) Levels to watch are 10806.9 and 10731.7

2) Sell Below 10690.89 SL 10721.89 TGT 10650.15, 10625.15
3) Buy Above 10752.89 SL 10721.89 TGT 10806.9, 10831.8, 10875.75

4) Supports/Resistances to Watch For :-

10650.15
10681.4
10725.35
10756.6
10800.55
10831.8
10875.75

Camarilla Calls:
1) Sell Below 10727.94 SL 10748.62 TGT 10684.07, 10666.03
2) Sell Below 10789.98 SL 10810.66 TGT 10776.19, 10762.41, 10748.62
3) Buy Above 10748.62 SL 10727.94 TGT 10762.41, 10776.19, 10789.98
4) Buy Above 10810.66 SL 10789.98 TGT 10834.47


BANKNIFTY : Levels to watch are 26243.6 and 26013.3

USDINR-1 : Levels to watch are 67.54 and 67.29

RELIANCE : Levels to watch are 989.72 and 969.08

SBIN : Levels to watch are 250.17 and 246.12

Position as per Trade with Trend :

NIFTY Hold Long taken at 10737.22 On 07-05-2018 StopLoss 10679.25 | Profit so far 32.08

BANKNIFTY Hold Long taken at 25027.6 On 27-04-2018 StopLoss 25875.47 | Profit so far 1100.85

RELIANCE Hold Long taken at 973.02 On 07-05-2018 StopLoss 964.43 | Profit so far 6.38

SBIN Hold Long taken at 241.25 On 27-04-2018 StopLoss 244.32 | Profit so far 6.9


Nifty Options Data:
Highest OI : NIFTY10500PE NIFTY11000CE
Highest Rise in OI : NIFTY10700PE NIFTY10850CE
Highest Fall in OI : NIFTY11000PE NIFTY11000CE
Highest Volume : NIFTY10700PE NIFTY10800CE


FII/DII Figures:
FII Cash Net = N.A.
FII F&O Net = 919.13
FII F&O OI = 173066.7
DII Cash Net = N.A.


Long Build Up: KAJARIACER, STAR, ARVIND, IDBI, GAIL
Short Covering: TATAMTRDVR, TORNTPHARM, ICICIPRULI, HEXAWARE, TATAMOTORS

Short Build Up: CHOLAFIN, AMBUJACEM, APOLLOHOSP, ESCORTS, NCC
Long Unwinding: JUBLFOOD, DALMIABHA, NIITTECH, EXIDEIND, WOCKPHARMA


Volume Shockers (Futures) :
ARVIND

Swing Trading (Futures):
NIL


5 Best Performing Stocks since Expiry:
HEG, FSL, LAXMIMACH, GRAPHITE, ASTRAZEN

5 Worst Performing Stocks since Expiry:
ALOKTEXT, HCC, LITL, JETAIRWAYS, AJANTPHARM

No comments:

Post a Comment